FRONTIER BIOPHARMA LIMITED

Active Wokingham

Activities of production holding companies

367 employees website.com
Activities of production holding companies
F

FRONTIER BIOPHARMA LIMITED

Activities of production holding companies

Founded 20 Jan 2021 Active Wokingham, United Kingdom 367 employees website.com
Activities of production holding companies

Previous Company Names

DRINA HOLDINGS LIMITED 20 Jan 2021 — 7 Sept 2023
Accounts Submitted 24 Oct 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 22 Jan 2026 Next due 2 Feb 2027 9 months remaining
Net assets £11M £1M 2024 year on year
Total assets £32M £604K 2024 year on year
Total Liabilities £21M £857K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Flb Accountants Llp 1010 Eskdale Road Winnersh Triangle Wokingham RG41 5TS United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for FRONTIER BIOPHARMA LIMITED (13146422), an active company based in Wokingham, United Kingdom. Incorporated 20 Jan 2021. Activities of production holding companies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2021–2024)

Cash in Bank

£724.71k

Decreased by £5.10k (-1%)

Net Assets

£10.85M

Decreased by £1.46M (-12%)

Total Liabilities

£21.19M

Increased by £857.30k (+4%)

Turnover

£25.13M

Decreased by £1.87M (-7%)

Employees

367

Increased by 23 (+7%)

Debt Ratio

66%

Increased by 4 (+6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 6,154,552 Shares £6.15m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Jul 2024600,000€600k€1
18 Mar 20213,823,126£3.82m£1
18 Mar 20211,731,226£1.73m£1
2 Feb 2021200£200£1

Officers

Officers

3 active
Status
Kaye, Steven JonathanDirectorBritishEngland602 Feb 2021Active
Kiren Lee NaidooDirectorBritishUnited Kingdom4020 Jan 2021Active
Mehmet Levent SelamogluDirectorTurkishTurkey6620 Jan 2021Active

Shareholders

Shareholders (11)

Bonnefleur Ltd
62.1%
3,823,126
Frontier Pharma Limited
14.1%
865,763

Persons with Significant Control

Persons with Significant Control (3)

3 Active 2 Ceased
Active
Notified 2 Feb 2021
Nature of Control
  • Voting Rights 25 To 50 Percent

Joseph Ensink

Dutch

Active
Notified 25 Jul 2024
Residence Guernsey
DOB April 1964
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Mr Joseph Ensink

Dutch

Active
Notified 25 Jul 2024
Residence Guernsey
DOB April 1964
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Kiren Lee Naidoo

Ceased 5 Mar 2024

Ceased

Joseph Ensink

Ceased 5 Mar 2024

Ceased

Group Structure

Group Structure

FRONTIER BIOPHARMA LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Jan 2026Confirmation StatementConfirmation statement made on 19 Jan 2026 with no updates
24 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
27 Jan 2025Confirmation StatementConfirmation statement made on 19 Jan 2025 with updates
13 Nov 2024AccountsAnnual accounts made up to 31 Dec 2023
21 Oct 2024IncorporationMemorandum Articles
22 Jan 2026 Confirmation Statement

Confirmation statement made on 19 Jan 2026 with no updates

24 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

27 Jan 2025 Confirmation Statement

Confirmation statement made on 19 Jan 2025 with updates

13 Nov 2024 Accounts

Annual accounts made up to 31 Dec 2023

21 Oct 2024 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 19 Jan 2026 with no updates

3 months ago on 22 Jan 2026

Annual accounts made up to 31 Dec 2024

6 months ago on 24 Oct 2025

Confirmation statement made on 19 Jan 2025 with updates

1 years ago on 27 Jan 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 13 Nov 2024

Memorandum Articles

1 years ago on 21 Oct 2024